Voloridge Investment Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,119
Closed -$207K 1590
2023
Q1
$207K Buy
+8,119
New +$207K ﹤0.01% 1310